Company
United StatesPublic company, NASDAQ: AKBAAkebia Therapeutics, Inc. (NASDAQ: AKBA), Cambridge, MA – FDA Inspections
Inspection records and compliance data for Akebia Therapeutics, Inc. in Cambridge, Massachusetts. 1 FDA inspection on record, last inspected August 12, 2021. Publicly traded as NASDAQ: AKBA.
Company Profile
This profile covers Akebia Therapeutics, Inc. based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 12, 2021.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 12, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1150511 |
FDA documents
Other FDA documents (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Akebia Therapeutics, Inc.
Stock ticker
AKBA
Exchange
NASDAQ
Share price
$0.50
Market cap
$138.3M
Price as of
November 13, 2026
FEI Number
3012772815
Address
245 1st St, Cambridge, Massachusetts 02142, United States
Country
United States
ID: b838f792-0f4d-4712-b689-8ec9fe97c0b9